Chemoinformaics analysis of Gamma-L-Glutamyl-S-(2-Carboxy-1-Propyl)-Cysteineglycine
| Molecular Weight | 393.418 | nRot | 13 |
| Heavy Atom Molecular Weight | 370.234 | nRig | 5 |
| Exact Molecular Weight | 393.121 | nRing | 0 |
| Solubility: LogS | -1.513 | nHRing | 0 |
| Solubility: LogP | -3.86 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 51.3322 |
| nHD | 6 | BPOL | 30.4438 |
| QED | 0.21 |
| Synth | 3.44 |
| Natural Product Likeliness | 0.515 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.539 |
| HIA | 0.095 |
| CACO-2 | -6.887 |
| MDCK | 0.0000115 |
| BBB | 0.054 |
| PPB | 0.125456 |
| VDSS | 0.386 |
| FU | 0.74039 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.005 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.025 |
| CYP2c9-inh | 0.129 |
| CYP2c9-sub | 0.558 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0 |
| CL | 2.209 |
| T12 | 0.857 |
| hERG | 0.01 |
| Ames | 0.012 |
| ROA | 0.002 |
| SkinSen | 0.105 |
| Carcinogencity | 0.035 |
| EI | 0.045 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.834198 |